Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics

European Journal of Radiology

Volumn 75, Issue 3, 2010, Pages 329-335

  Chen, Zhengguang ^a   Li, Xiaozhen ^b   Li, Fang ^b   Ouyang, Qiaohong ^c   Yu, Tong ^d  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Metastases; Pediatric tumors; PET CT

Indexed keywords

COMPUTERIZED TOMOGRAPHY; METABOLISM; NORMAL DISTRIBUTION; PATHOLOGY; PATIENT TREATMENT; PEDIATRICS; POSITRON EMISSION TOMOGRAPHY; TUMORS;

ANATOMICAL INFORMATION; HIGH QUALITY IMAGES; METABOLIC ACTIVITY; METABOLIC IMAGING; METASTASES; METASTATIC DISEASE; PEDIATRIC PATIENTS; TREATMENT PLANNING;

DIAGNOSIS;

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CHILDHOOD CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; METASTASIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; REVIEW; TREATMENT PLANNING; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; WHOLE BODY CT; WHOLE BODY PET; COMPUTER ASSISTED TOMOGRAPHY; FORECASTING; IMAGE SUBTRACTION; LYMPH NODE METASTASIS; METHODOLOGY; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; WHOLE BODY IMAGING;

FLUORODEOXYGLUCOSE F18; FORECASTING; HUMANS; LYMPHATIC METASTASIS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 77956961016     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.05.039     Document Type: Article

References (25)

1. H. Jadvar, L.P. Connolly, and F.H. Fahey PET and PET/CT in pediatric oncology Semin Nucl Med 37 2007 316 331
2. T. Beyer, D.W. Townsend, and T. Brun A combined PET/CT scanner for clinical oncology J Nucl Med 41 8 2000 1369 1379
3. K. Pacak, G. Eisenhofer, and D.S. Goldstein Functional imaging of endocrine tumors: role of positron emission tomography Endocr Rev 25 4 2004 568 580
4. B.L. Shulkin, S. Mitchell, and R. Ungar Neoplasms in a pediatric population: 2-IF-1 8I-fluoro-2-deoxy-d-glucose PET studies Radiology 194 1995 495 550
5. 18F-FDG PET in pediatric lymphomas: a comparison with conventional imaging Cancer Biother Radiopharm 23 6 2008 1 9
6. 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients J Comput Assist Tomogr 30 2006 689 694
7. J.M. Levine, M. Weiner, and K.M. Kelly Routine use of PET scans after completion of therapy in pediatric hodgkin disease results in a high false positive rate J Pediatr Hematol Oncol 28 2006 711 714
8. D.B. Beker, S.G. Berrak, and C. Canpolat False positivity of FDG-PET/CT in a child with Hodgkin disease Pediatr Blood Cancer 50 2008 881 883
9. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's Pediatr Radiol 35 2005 141 154
10. 18]fluoro-d-glucose-positron emission tomography studies in cancer patients J Nucl Med 44 November (11) 2003 1789 1796
11. 18F-FDG PET: age dependency and frequency after chemotherapy J Nucl Med 42 April (4) 2001 591 595
12. 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma Pediatr Blood Cancer 49 7 2007 901 905
13. H.R. Nadel, and M.A. Rossleigh Tumor imaging S.T. Treves, Pediatric nuclear medicine 2nd ed. 1995 Springer-Verlag New York 496 527
14. 18F flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma Leukemia Lymphoma 48 April (4) 2007 699 707
15. M. Hines-Thomas, S.C. Kaste, and M.M. Hudson Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma Pediatr Blood Cancer 51 2008 198 203
16. 18F-FDG-PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma Nucl Med Commun 20 1999 13 20 (Pubitemid 29084592)
17. 18F-FDG-PET in children with lymphomas Eur J Nucl Med Mol Imaging 32 2005 31 38
18. H. Amthauer, C. Furth, and T. Denecke FDG-PET in 10 children with non-Hodgkin's lymphoma: initial experience in staging and followup Klin Pediatr 217 2005 327 333
19. M. Hernandez-Pampaloni, A. Takalkar, and J.Q. Yu F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas Pediatr Radiol 36 2006 524 531
20. E. Kabickova, D. Sumerauer, and E. Cumlivska Comparison of (18)FFDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease Eur J Nucl Med Mol Imaging 33 2006 1025 1031
21. R. Moody, B. Shulkin, and G. Yanik PET FDG imaging in pediatric lymphomas J Nucl Med 42 5 suppl. 2001 39P
22. K. Keresztes, Z. Lengyel, and K. Devenyi Mediastinal bulky tumor in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post treatment residual masses Acta Haematol 112 2004 194 199
23. W.C. Lavely, D. Delbeke, and J.P. Greer FDG-PET in the follow-up of management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy Int J Radiat Oncol Biol Phys 57 2003 307 315
24. 18F-FDG PET/CT in evaluating non-CNS pediatric malignancies J Nucl Med 48 2007 1923 1931
25. M.M. Rhodes, D. Delbeke, and J.A. Whitlock Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma J Pediatr Hematol Oncol 28 2006 300 306